Literature DB >> 28385355

Devices for management of sudden cardiac death: Successes, challenges and perspectives.

Nikolaos Dagres1, Gerhard Hindricks2.   

Abstract

Over the last decades, tremendous successes have been achieved in the management of sudden cardiac death in patients with heart failure by use of the implantable cardioverter-defibrillators. However, dramatic changes in the overall treatment of these patients have led to a significantly changed risk for sudden cardiac death. This renders a reevaluation of the role of devices for primary prevention of sudden cardiac death in patients receiving up-to-date optimal care imperative.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28385355     DOI: 10.1016/j.ijcard.2017.03.053

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Short-term effects of ambient air pollutants and myocardial infarction in Changzhou, China.

Authors:  Yongquan Yu; Shen Yao; Huibin Dong; Minghui Ji; Zhiyong Chen; Guiying Li; Xingjuan Yao; Shou-Lin Wang; Zhan Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-28       Impact factor: 4.223

2.  Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis.

Authors:  Marcello Disertori; Michela Masè; Marta Rigoni; Giandomenico Nollo; Flavia Ravelli
Journal:  Int J Cardiol Heart Vasc       Date:  2018-06-14

3.  Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study.

Authors:  Ari Pelli; M Juhani Junttila; Tuomas V Kenttä; Simon Schlögl; Markus Zabel; Marek Malik; Tobias Reichlin; Rik Willems; Marc A Vos; Markus Harden; Tim Friede; Christian Sticherling; Heikki V Huikuri
Journal:  Europace       Date:  2022-05-03       Impact factor: 5.486

4.  Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project.

Authors:  Moritz Hadwiger; Nikolaos Dagres; Janina Haug; Michael Wolf; Ursula Marschall; Jan Tijssen; Alexander Katalinic; Fabian Simon Frielitz; Gerhard Hindricks
Journal:  Eur Heart J       Date:  2022-07-14       Impact factor: 35.855

5.  A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data.

Authors:  Moritz Hadwiger; Laura Schumann; Nora Eisemann; Nikolaos Dagres; Gerhard Hindricks; Janina Haug; Michael Wolf; Ursula Marschall; Alexander Katalinic; Fabian-Simon Frielitz
Journal:  Cost Eff Resour Alloc       Date:  2022-09-02

6.  Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation.

Authors:  Markus Zabel; Christian Sticherling; Rik Willems; Andrzej Lubinski; Axel Bauer; Leonard Bergau; Frieder Braunschweig; Josep Brugada; Sandro Brusich; David Conen; Iwona Cygankiewicz; Panagiota Flevari; Milos Taborsky; Jim Hansen; Gerd Hasenfuß; Robert Hatala; Heikki V Huikuri; Svetoslav Iovev; Stefan Kääb; Gabriela Kaliska; Jaroslaw D Kasprzak; Lars Lüthje; Marek Malik; Tomas Novotny; Nikola Pavlović; Georg Schmidt; Tchavdar Shalganov; Rajeeva Sritharan; Simon Schlögl; Janko Szavits Nossan; Vassil Traykov; Anton E Tuinenburg; Vasil Velchev; Marc A Vos; Stefan N Willich; Tim Friede; Jesper Hastrup Svendsen; Béla Merkely
Journal:  ESC Heart Fail       Date:  2018-10-09

7.  Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.

Authors:  Markus Zabel; Rik Willems; Andrzej Lubinski; Axel Bauer; Josep Brugada; David Conen; Panagiota Flevari; Gerd Hasenfuß; Martin Svetlosak; Heikki V Huikuri; Marek Malik; Nikola Pavlović; Georg Schmidt; Rajevaa Sritharan; Simon Schlögl; Janko Szavits-Nossan; Vassil Traykov; Anton E Tuinenburg; Stefan N Willich; Markus Harden; Tim Friede; Jesper Hastrup Svendsen; Christian Sticherling; Béla Merkely
Journal:  Eur Heart J       Date:  2020-09-21       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.